Banned antipsychotic medicine
Trifluperidol (INN)
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
Trifluperidol is a prescription antipsychotic drug related to haloperidol. It is a medicine intended for treatment of severe mental illness, not a cosmetic, and is banned from personal care products in the EU.
Skin benefits
- Antipsychotic medicine for schizophrenia and acute mania
- No cosmetic role at all
Known concerns
- Prescription butyrophenone antipsychotic, not a cosmetic ingredient
- Risk of extrapyramidal symptoms, neuroleptic malignant syndrome
- Banned from cosmetic products under EU Annex II
- Systemic absorption could cause neurological adverse effects
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Check your shelf
Find Trifluperidol (INN) in your products.
Scan any cosmetic product with LuxSense to see if it contains Trifluperidol (INN) and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.